Tumour protein D54 (TPD52L2) had a threefold higher concentration in endometrial cancer compared to controls while the molecular chaperone endoplasmin (HSP90B1) had a threefold lower concentration (Fig. 1d). This evidence concerns the gene HSP90B1 and endometrial cancer.